Skip to content

Evaluation of clinical effect of comprehensive treatment of keloids

Clinical effect of combined treatment with glucocorticoid and 5 fluorouracil subcutaneous injection after surgical resection and radiotherapy on keloids

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030211
Enrollment
Unknown
Registered
2020-02-25
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid

Interventions

Group 2:Comprehensive treatment

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The skin damage exceeds the original damage scope and invades the surrounding normal skin; 2. Symptoms of spontaneous regression of scars over 9 months; 3. Those who have had resection before and have relapsed; 4. Anyone who meets one or more of the above can be diagnosed.

Exclusion criteria

Exclusion criteria: 1. Women during pregnancy or lactation or preparing to become pregnant; 2. People with severe liver and kidney dysfunction; people with severe heart disease; 3. Oral antihistamines within 2 weeks; 4. One month of local injection of hormones into endothelial lesions; 5. People with active ulcers; 6. Keloid surface area > 10 cm2.

Design outcomes

Primary

MeasureTime frame
cure,partial cure, not cure;

Countries

China

Contacts

Public ContactNiu Xingtang

The First Affiliated Hospital of Sun Yat-Sen University

niuxingtang@163.com+86 13560375885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026